News
- Author:
- Zosia Chustecka
Publish date: June 16, 2023
Glofitamab, a T cell–engaging bispecific antibody, has been approved by the Food and Drug Administration for adults with DLBCL.
News
- Author:
- Zosia Chustecka
Publish date: March 20, 2023
But military aircrew and ground crew were less likely to die from cancer, compared with the U.S. population.
News
- Author:
- Zosia Chustecka
Publish date: February 27, 2023
Exorbitantly priced gene therapy to treat hemophilia B has been approved for sale across the European Union and European Economic Area.
News
- Author:
- Zosia Chustecka
Publish date: February 24, 2023
Newly approved by the FDA, this replacement therapy for a rare bleeding disorder has been found to reduce both dosing frequency and bleeds.
News
- Author:
- Zosia Chustecka
Publish date: December 23, 2022
New treatment for relapsed/refractory follicular lymphoma, newly approved by the FDA, showed effectiveness in research presented at ASH 2022.
News
- Author:
- Zosia Chustecka
Publish date: December 5, 2022
Olutasidenib has been green-lighted by the FDA for treatment of some patients with acute myeloid leukemia.
News
- Author:
- Zosia Chustecka
Publish date: December 1, 2022
The clinical data the company submitted was deemed insufficient for approval.
News
- Author:
- Zosia Chustecka
Publish date: December 1, 2022
The anti-PD-L1 inhibitor continues to be approved for lung and liver cancers and melanoma.
News
- Author:
- Zosia Chustecka
Publish date: November 22, 2022
As requested by the U.S. Food and Drug Administration, the multiple myeloma drug blenrep is being taken off the market after disappointing results ...
News
- Author:
- Zosia Chustecka
Publish date: October 24, 2022
The Food and Drug Administration has approved a new immunotherapy combination for use in the treatme...
News
- Author:
- Zosia Chustecka
Publish date: October 3, 2022
Futibatinib is “a key example of the potential of precision medicine” in intrahepatic cholangiocarcinoma.
News
- Author:
- Zosia Chustecka
Publish date: August 26, 2022
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.
News
- Author:
- Zosia Chustecka
Publish date: August 17, 2022
Oncologists’ income rose, on average, by 2% in the past year and now stands at an average of $411,000 annually.
News
- Author:
- Zosia Chustecka
Publish date: August 12, 2022
“These results establish the new standard of care for patients with NSCLC harboring HER2 mutations.”
News
- Author:
- Zosia Chustecka
Publish date: June 3, 2022
The theme of the 2022 meeting is advancing equitable cancer care through innovation.
